Manulife (Manufacturers Life Insurance)’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio RXDX Stock Details RXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-41,883	Closed	-$4.49M	–	3107
2023 Q1	$4.49M	Buy	41,883 +9,556	+30%	+$1.1M	﹤0.01%	1140
2022 Q4	$3.56M	Buy	32,327 +16,120	+99%	+$1.05M	﹤0.01%	1211
2022 Q3	$950K	Buy	16,207 +4,283	+36%	+$196K	﹤0.01%	1629
2022 Q2	$337K	Sell	11,924 -119	-1%	-$3.45K	﹤0.01%	2316
2022 Q1	$455K	Sell	12,043 -2,748	-19%	-$109K	﹤0.01%	2264
2021 Q4	$585	Buy	+14,791	New	+$463K	﹤0.01%	2167

Other funds holding RXDX

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s RXDX Position: Q2 2023 in Review

Manulife (Manufacturers Life Insurance) sold out of Prometheus Biosciences, Inc. Common Stock (RXDX) in Q2 2023, closing a stake of 41,883 shares — an estimated $4.49M sold.

Manulife (Manufacturers Life Insurance) first reported a position in RXDX in Q4 2021 and held it in 6 quarters. The position peaked at $4.49M in Q1 2023. 2 funds tracked by Wall St. Rank hold RXDX as of Q2 2023.

Manulife (Manufacturers Life Insurance) reported no remaining Prometheus Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Manulife (Manufacturers Life Insurance) sold 41,883 Prometheus Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $4.49M.
Manulife (Manufacturers Life Insurance) first reported a position in Prometheus Biosciences, Inc. Common Stock in Q4 2021 and held it in 6 quarters.
Manulife (Manufacturers Life Insurance)'s Prometheus Biosciences, Inc. Common Stock position peaked at $4.49M in Q1 2023.
2 funds tracked by Wall St. Rank held Prometheus Biosciences, Inc. Common Stock as of Q2 2023.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2023, filed 11 Aug 2023.